VolitionRx Ltd Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Income Taxes

Income Taxes

12 Months Ended

Dec. 31, 2015

The Company has estimated net operating losses for the years ended December 31, 2015 and 2014 of $8,774,691 and $7,141,271, respectively, available to offset taxable income in future years.

The Company is subject to Singapore income taxes at a rate of 17 percent, Belgium income taxes at a rate of 34 percent, UK taxes at a rate of 20.25 percent and U.S. taxes at a rate of 35 percent, for a weighted average of 26 and 32 percent, respectively. The reconciliation of the provision for income taxes at the weighted average rate compared to the Company's income tax expense as reported is as follows:

	2015 $			2014 $

Net loss		(9,530,242	)		(8,213,529	)
Tax adjustments		755,551			1,072,258
Estimated net operating losses		(8,774,691	)		(7,141,271	)

Tax rate		26	%		32	%

Income tax recovery at statutory rate		(2,306,549	)		(2,247,408	)

Valuation allowance		2,306,549			2,247,408

Refund received re previous tax year		(4,604	)		–
Provision for income taxes		4,604			–

The significant components of deferred income taxes and assets as at December 31, 2015 are as follows:

	2015 $			2014 $

Net operating losses carried forward		5,792,392			4,295,152

Valuation allowance		(5,792,392	)		(4,295,152	)

Net deferred income tax asset		-			–